Loncastuximab tesirine, CAS [[1879918-31-6]]

Produktübersicht

• Artikelname: Loncastuximab tesirine, CAS [[1879918-31-6]]
• Artikelnummer: MCE-HY-P99349
• Hersteller Artikelnummer: HY-P99349
• Alternativnummer: MCE-HY-P99349-1MG,MCE-HY-P99349-500UG,MCE-HY-P99349-100UG,MCE-HY-P99349-200UG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Loncastuximab tesirine-lpyl, ADCT-402

Produktbeschreibung

Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). The antibody portion is Loncastuximab (HY-P99711), and the drug-linker conjugate for ADC is Tesirine (HY-128952). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma[1][2].

Produkteigenschaften

• Molekulargewicht: 147000 (average)
• Reinheit: 99.37
• CAS Nummer: [1879918-31-6]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),Apoptosis

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related